Search Results

Summary NGN2 antibody is predicted to not cross-react with neurogenin 1.

Summary This antibody's epitope is resistant to digestion by trypsin and chymotrypsin. This MAb selectively interferes with lymphocyte binding to lymph node, mucosal and synovial endothelium.

Summary At least three isoforms are known to exist; this antibody will detect all three. This antibody is predicted not to cross-react with SLAIN2.

Summary Recognizes a protein of 210-220kDa, which is identified as the complement receptor 1 (CR1)/CD35. This MAb does not block CR1 activity. It is highly specific to CR1 and shows no cross-reaction with CR2.

Summary At least two are known to exist; DRGX antibody is predicted to not cross-react with other Homeodomain proteins.

Summary This antibody reacts with CD14, a 53-55 kDa GPI (glycosylphosphatidylinositol)-linked membrane glycoprotein expressed on monocytes, macrophages and weakly on granulocytes; also expressed by most tissue macrophages. In human, the epitope recognized by MEM-18 is located between amino acids 57-64.